The premier interdisciplinary rehabilitation solution since 2003! Brainworks focuses in client-centred rehabilitation services for individuals who have been seriously injured in motor vehicle collisions, and their families. Brainworks offers innovative treatment programs to individuals with brain injury, chronic pain, depression & sleep disturbances. We provide direct rehabilitation services north of Toronto to north of Sudbury, with consultation, education & eRehabilitation service capabilities throughout Ontario.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

ACQUISITION OF UPRISE, A WORLD CLASS DIGITAL HEALTH PLATFORM, STRENGTHENS THE POSITION OF THE IBH AS THE LEADING AGENCY FOR PUBLIC HEALTH

IBH | March 31, 2021

news image

IBH, a population, and digital health services pioneer, announced the acquisition of Uprise, a digital health platform that delivers highly customized treatment through self-guided modules, live coaching, and in-person counseling. The acquisition of Uprise follows IBH's latest acquisition of HMC HealthWorks in December 2020, which expanded IBH's presence in chronic disease management. This new ac...

Read More

HEALTH TECHNOLOGY

NFERENCE LAUNCHES AI-DRIVEN PLATFORM AND EXPANDS PARTNERSHIP WITH MAYO CLINIC, OFFERING ACCESS TO ONE OF THE DEEPEST REAL-WORLD

nference | September 22, 2022

news image

nference, a science-first software company transforming healthcare by making biomedical data computable announced the launch of its AI-driven nSights platform, which will allow biopharma, medical device companies, and diagnostic firms to access and directly engage with curated, de-identified healthcare data to advance research and discovery. The company also expanded its exclusive 12-year strategic relationship with Mayo Clinic, providing nference partners and customers with access ...

Read More

HEALTHCARE ANALYTICS

SYMPLR COMPLETES ACQUISITION OF MIDAS HEALTH ANALYTICS SOLUTIONS FROM CONDUENT

symplr | February 10, 2022

news image

symplr®, the leader in enterprise healthcare operations including governance, risk management, and compliance ("GRC") SaaS solutions, backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and Charlesbank Capital Partners (together with its affiliates, "Charlesbank"), announced today that it has completed its acquisition of Midas Health Analytics Solutions ("Midas") from Conduent Incorporated("Conduent")...

Read More

AI DRUG DISCOVERY PLATFORM IDS POTENTIAL COVID-19 TREATMENTS

HITInfrastructure | March 26, 2020

news image

A drug discovery platform powered by artificial intelligence (AI) technology has identified 18 potential treatments for COVID-19, according to an annuncement from health IT company Gero. Six of the potential anti-COVID-19 drugs have already been approved, three have been withdrawn, and the other nine have already been tested in clinical trials for other indications. The COVID-19 outbreak and the legal and regulatory status of these drugs have made it possible to start various clinical tria...

Read More
news image

ACQUISITION OF UPRISE, A WORLD CLASS DIGITAL HEALTH PLATFORM, STRENGTHENS THE POSITION OF THE IBH AS THE LEADING AGENCY FOR PUBLIC HEALTH

IBH | March 31, 2021

IBH, a population, and digital health services pioneer, announced the acquisition of Uprise, a digital health platform that delivers highly customized treatment through self-guided modules, live coaching, and in-person counseling. The acquisition of Uprise follows IBH's latest acquisition of HMC HealthWorks in December 2020, which expanded IBH's presence in chronic disease management. This new ac...

Read More
news image

HEALTH TECHNOLOGY

NFERENCE LAUNCHES AI-DRIVEN PLATFORM AND EXPANDS PARTNERSHIP WITH MAYO CLINIC, OFFERING ACCESS TO ONE OF THE DEEPEST REAL-WORLD

nference | September 22, 2022

nference, a science-first software company transforming healthcare by making biomedical data computable announced the launch of its AI-driven nSights platform, which will allow biopharma, medical device companies, and diagnostic firms to access and directly engage with curated, de-identified healthcare data to advance research and discovery. The company also expanded its exclusive 12-year strategic relationship with Mayo Clinic, providing nference partners and customers with access ...

Read More
news image

HEALTHCARE ANALYTICS

SYMPLR COMPLETES ACQUISITION OF MIDAS HEALTH ANALYTICS SOLUTIONS FROM CONDUENT

symplr | February 10, 2022

symplr®, the leader in enterprise healthcare operations including governance, risk management, and compliance ("GRC") SaaS solutions, backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and Charlesbank Capital Partners (together with its affiliates, "Charlesbank"), announced today that it has completed its acquisition of Midas Health Analytics Solutions ("Midas") from Conduent Incorporated("Conduent")...

Read More
news image

AI DRUG DISCOVERY PLATFORM IDS POTENTIAL COVID-19 TREATMENTS

HITInfrastructure | March 26, 2020

A drug discovery platform powered by artificial intelligence (AI) technology has identified 18 potential treatments for COVID-19, according to an annuncement from health IT company Gero. Six of the potential anti-COVID-19 drugs have already been approved, three have been withdrawn, and the other nine have already been tested in clinical trials for other indications. The COVID-19 outbreak and the legal and regulatory status of these drugs have made it possible to start various clinical tria...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us